Skip to content

Intermittent Pneumatic Impulse Compression in the treatment of stasis dermatitis – a monocenter randomized controlled trial

Intermittent Pneumatic Impulse Compression in the treatment of stasis dermatitis – a monocenter randomized controlled trial - Efficacy testing of edema reduction, tissue perfusion and pain relief in congestive dermatitis with IIK (VADOplex®)

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00036454
Enrollment
20
Registered
2025-03-24
Start date
2021-04-05
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

I83.9

Interventions

Group 1: Elastocompressive bandages + Intermittent Impulse Compression as part of inpatient treatment for 5 days (split-body-study) Group 2: Elastocompressive bandages (Standard of Care, SOC) as part

Sponsors

Klinik für Dermatologie
Lead Sponsor

Eligibility

Sex/Gender
All
Age
30 Years to 100 Years

Inclusion criteria

Inclusion criteria: Patients aged between 30-100 years Written informed consent Diagnosis of stasis dermatitis

Exclusion criteria

Exclusion criteria: - Patient age under 30 and over 100 years - Absence of a written declaration of consent - Acute untreated serious infection on affected extremity - Acute decompensated cardiac insufficiency - Signs of dermatoliposclerosis - Lipedema - Acute phlebitis (inflammation of the veins) or - Acute thrombosis or pulmonary embolism

Design outcomes

Primary

MeasureTime frame
3-point measurement (ankle, 10 cm below the kneecap, 15 cm above the kneecap) Pain sensation (NRS 0-10/10) Transcutaneous oxygen pressure (tcpO2) (below the knee, foot) The measurements are taken before the start of therapy, after one day and at the end of the inpatient stay after 5 days.

Secondary

MeasureTime frame
Skin assessment of stasis dermatitis Healing process The measurements are taken before the start of therapy, after one day and at the end of the inpatient stay after 5 days.

Countries

Germany

Contacts

Public ContactSarah Janßen

Klinik für Dermatologie

sarah.janssen@med.uni-duesseldorf.de+49 211 81 17617

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026